We are live on ! Find out more
FLNA

Filana Therapeutics

149 hedge funds and large institutions have $279M invested in Filana Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less call options, than puts

Call options by funds: $106M | Put options by funds: $109M

1.36% less ownership

Funds ownership: 26.25%24.89% (-1.4%)

9% less funds holding

Funds holding: 163149 (-14)

24% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 51

28% less capital invested

Capital invested by funds: $390M → $279M (-$111M)

43% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 28

Holders
149
Holders Change
-14
Holders Change %
-8.59%
% of All Funds
2.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
39
Reduced
51
Closed
28
Calls
$106M
Puts
$109M
Net Calls
-$2.45M
Net Calls Change
+$65.4M
Name Holding Trade Value Shares
Change
Change in
Stake
SO
76
STRS Ohio
Ohio
$210K +$10.1K +400 +6%
Russell Investments Group
77
Russell Investments Group
United Kingdom
$205K
ASN
78
Advisory Services Network
Georgia
$174K +$5.18K +205 +3%
AB
79
Amalgamated Bank
New York
$170K -$5.33K -211 -3%
Fifth Third Bancorp
80
Fifth Third Bancorp
Ohio
$166K +$149K +5,900 New
Public Employees Retirement Association of Colorado
81
Public Employees Retirement Association of Colorado
Colorado
$151K
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$145K -$10.9K -432 -8%
Zurich Cantonal Bank
83
Zurich Cantonal Bank
Switzerland
$142K
US Bancorp
84
US Bancorp
Minnesota
$142K +$20.2K +799 +19%
BL
85
Bleichroeder LP
New York
$141K
UBS Group
86
UBS Group
Switzerland
$140K -$33.4K -1,323 -21%
VEA
87
Virtus ETF Advisers
New York
$119K +$23.8K +942 +29%
PNC Financial Services Group
88
PNC Financial Services Group
Pennsylvania
$88K -$25.3K -1,000 -24%
AIP
89
Ameritas Investment Partners
Nebraska
$84K
BAM
90
Byrne Asset Management
New Jersey
$73K -$31.1K -1,230 -35%
LSA
91
Leonteq Securities AG
Switzerland
$70.3K
MLICM
92
Metropolitan Life Insurance Company (MetLife)
New York
$66.7K
Wells Fargo
93
Wells Fargo
California
$64K -$197K -7,783 -77%
FDCDDQ
94
Federation des caisses Desjardins du Quebec
Quebec, Canada
$60.3K
Canada Life
95
Canada Life
Manitoba, Canada
$58K
SAM
96
Shell Asset Management
Netherlands
$51K +$682 +27 +2%
Federated Hermes
97
Federated Hermes
Pennsylvania
$43K +$38.6K +1,527 New
Macquarie Group
98
Macquarie Group
Australia
$41K
CFGS
99
Concourse Financial Group Securities
Alabama
$37K +$33.7K +1,333 New
Rockefeller Capital Management
100
Rockefeller Capital Management
New York
$35K

FLNA Hedge Fund Activity: Q2 2022 in Review

149 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2022, worth a combined $279M — down 28% from $390M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of FLNA and 16 opened new positions — a net loss of 12 holders — while 51 trimmed existing stakes and 39 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $5.5M. The largest seller was Group One Trading, cutting an estimated $5.18M.

  • 149 institutional investors held Filana Therapeutics (FLNA) as of Q2 2022, down from 163 in Q1 2022.
  • Funds reported $279M of Filana Therapeutics stock for Q2 2022, down 28% quarter-over-quarter.
  • 16 funds opened new Filana Therapeutics positions in Q2 2022 and 28 closed out, a net change of -12 holders.
  • The largest Filana Therapeutics buyer in Q2 2022 was BNP Paribas Financial Markets, an estimated $5.5M added.
  • The largest Filana Therapeutics seller in Q2 2022 was Group One Trading, an estimated $5.18M sold.

Based on aggregated 13F filings for Q2 2022.